Loading match intelligence
A drug candidate discovered using artificial intelligence as a primary method begins its first Phase I trial (first patient dosed) on or before 2027-06-28, as registered on ClinicalTrials.gov.
Resolves Yes if A drug candidate discovered using artificial intelligence as a primary method begins its first Phase I trial (first patient dosed) on or before 2027-06-28, as registered on ClinicalTrials.gov.
Outcome verified from clinicaltrials.gov.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…